<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> are reported to have an increased risk of <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the underlying causes remain unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the longitudinal associations between midlife insulin secretion, <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, and the subsequent development of <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD) and <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The population-based Uppsala Longitudinal Study of Adult Men started 1970 when the 2,322 participants were 50 years old </plain></SENT>
<SENT sid="4" pm="."><plain>Investigation at baseline included determinations of <z:hpo ids='HP_0011009'>acute</z:hpo> insulin response and <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance using the IV <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test and Homeostasis Model Assessment <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> index </plain></SENT>
<SENT sid="5" pm="."><plain>During a median follow up of 32 years, 102 participants were diagnosed with AD, 57 with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, and 394 with any <z:hpo ids='HP_0000726'>dementia</z:hpo> or <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Associations were analyzed using Cox proportional hazard models </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: A low insulin response at baseline was associated with a higher cumulative risk of AD (hazard ratio for 1 SD decrease, 1.31; 95% CI, 1.10-1.56) also after adjustment for age, systolic blood pressure, body mass index, serum cholesterol, smoking, education level, and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>This association was stronger in subjects without the APOE epsilon4 allele </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000833'>Impaired glucose tolerance</z:hpo> increased the risk of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (hazard ratio for 1 SD decrease, 1.45; 95% CI, 1.05-2.00) but not AD </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0948379" disease_type="Disease or Syndrome" abbrv="">Impaired insulin secretion</z:e>, <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo>, and estimates of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> were <z:hpo ids='HP_0000001'>all</z:hpo> associated with higher risk of any <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: In this longitudinal study, impaired <z:hpo ids='HP_0011009'>acute</z:hpo> insulin response at midlife was associated with an increased risk of <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD) up to 35 years later suggesting a causal link between insulin metabolism and the pathogenesis of AD </plain></SENT>
</text></document>